Literature DB >> 33848633

Real-world efficacy and safety of Dupilumab use in the treatment of asthma.

Somaira Nowsheen1, Jared I Darveaux2.   

Abstract

Entities:  

Keywords:  Dupixent; asthma; biologic; dupilumab; effectiveness; immunotherapy; steroid

Year:  2021        PMID： 33848633     DOI： 10.1016/j.anai.2021.04.011

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN： 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  2 in total

Review 1.  Advances and Challenges of Antibody Therapeutics for Severe Bronchial Asthma.

Authors:  Yuko Abe; Yasuhiko Suga; Kiyoharu Fukushima; Hayase Ohata; Takayuki Niitsu; Hiroshi Nabeshima; Yasuharu Nagahama; Hiroshi Kida; Atsushi Kumanogoh
Journal:  Int J Mol Sci       Date:  2021-12-22       Impact factor: 5.923

2.  Reduced exacerbation frequency and prednisone dose in patients with ABPA and asthma treated with dupilumab.

Authors:  Tjeerd van der Veer; Marloes A Dallinga; Johanna P M van der Valk; Jasper H Kappen; Johannes C C M In 't Veen; Menno M van der Eerden; Gert-Jan Braunstahl
Journal:  Clin Transl Allergy       Date:  2021-12       Impact factor: 5.871
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.